Rh Isoimmunization.

Slides:



Advertisements
Similar presentations
Alloimmune Hemolytic Disease Of The Fetus / Newborn:
Advertisements

RHESUS (Rh) ISOIMMUNIZATION
DR. RAZAQ MASHA, FRCOG Consultant, Ob/Gyn Dept.
Rh ISOIMMUNIZATION Ghadeer Al-Shaikh, MD, FRCSC
USUHS MSIII Ob/Gyn Clerkship Self Directed Studies Isoimmunization Ch Academic Year MSIII Ob/Gyn Clerkship Self-Directed Study.
Rh ISOIMMUNIZATION By: DR
Hemolytic Disease of the Newborn Case #3
William 2001 I. Fetal anemia II. Fetomaternal hemorrhage III. Isoimmunisation IV. Immune hydrops V. Management VI. Pervention VII. Large fetomaternal.
District 1 ACOG Medical Student Education Module 2008
ALLOIMMUNIZATION IN PREGNANCY
Rh Incompatibility Patraporn Kinorn.
8th Edition APGO Objectives for Medical Students
ABO System & Pregnancy hemolytic diseases of the newborn may be due to ABO incompatibility O + O = O, O + A = O or A, O + B = O or B, O + AB = O or A.
Faculty of Allied Medical Science
بسم الله الرحمن الرحيم.
Dr. Sanjay Curpad. S. What is it?  A condition that has an adverse effect on the foetal red cells in response to the maternal immunization.
Hemolytic disease of newborn
Neonatal Jaundice Li weizhong.
Isoimmunization Erythroblastosis Fetalis Hemolytic Disease of the Newborn Zeev Weiner Director of Ultrasound in Obstetrics and Gynecology Lutheran Medical.
Dr. Afaf I. Alnoury RHESUS INCOMPATIBILITY بسم الله الرحمن الرحـيـم.
Fetal Haemolytic Disease. Maternal antibodies develop against fetal red blood cells IgG antibodies cross the placenta Haemolysis, anaemia, high-output.
MW / LS MT 417 – Clinical Hematology II Manual/Special Tests Unit Kleihauer-Betke Exercise KB Questions KEY.
Rh- Incompatability Rh- Isoimmunization
Blood Group Incompatibility in Pregnancy
Salwa Hindawi Rh-D Immunoglobulin Administration Salwa Hindawi Blood Transfusion Services KAUH.
Antibody Titer Case Studies
Presented by: Dr. Rozhan Yassin khalil FICOG,CABOG,HDOG,MBChB.
ABSTRACT NO : 160 ABSTRACT ID : IRIA A CASE REPORT ON IMMUNE HYDROPS FETALIS.
HAEMOLYTIC DISEASE OF THE NEW BORN (HDN)
RH-ISOIMMUNIZATION AND & ABO incompatibility
CLS 2215 Principles of Immunohematology
Pages  When blood is given intraveneously  Usually donated blood  Transfusions are given for:  Blood loss due to injury  Surgery  To supplement.
ALLOIMMUNIZATION IN PREGNANCY Brooke Grizzell, M.D. PGY-2 OBGYN Department, UKSM September 28 th, 2005.
Unit 11 Neonatal and Obstetrical Transfusion Practice – Part 3
Rh Factor ISOIMMUNIZATION Associate Professor Iolanda Blidaru, MD, PhD.
King Khalid University Hospital Department of Obstetrics & Gynecology Course 482.
DR.E.ZAREAN  First demonstrated by testing human blood with rabit anti sera against red cells of Rhesus monkey & classifying Rh negative & Rh positive.
IN THE NAME OF GOD. Cordocentesis Cordocentesis and IUT - History First intraperitoneal transfusion (Liley) Fetoscopy to obtain fetal samples.
Maternal Antibodies – Implications for the fetus/neonate
Rh – isoimmunization & ABO incompatibility
Dr: Dalia Galal Hamouda
Review of Blood type and Rh. Blood types and Blood groups  Blood Types- two parts the ABO part and the Rh part. A, B, O specify the types of proteins.
Rh-Blood TYPES.
Rh-Blood TYPES. Rh-Blood groups: Rh-Blood groups: The Rh-factor named for the rhesus monkey because it was first studied using the blood of this animal.
MLAB 1415: Hematology Keri Brophy-Martinez Chapter 11: Thalassemia Part Two.
Rh NEGATIVE PREGNANCY. The individual having the antigen on the human red cells is called Rh positive and in whom it is not present is called Rh negative.
Objective Define Erythroblastosis fetalis
BLOOD GROUPS AGGLUTINOGENS (Antigens) Complex oligosaccharide substances on the surface of the RBC membrane AGGLUTININS Antibodies against agglutinogens.
Dr. ARMAA A. AL SANJARY DEP.OBST.&GYN.
DR. RAZAQ MASHA, FRCOG Consultant, Ob/Gyn Dept.
Immunology of blood transfusion
Rh Alloimmunization (Isoimmunization)
Red Cell Alloimmunization in Pregnancy Case Presentation
New screening -Group B Streptococcus
Chapter 36 Hemolytic Disorders.
Rh(D) Alloimmunization
ISOIMMUNISATION.
DR. RAZAQ MASHA, FRCOG Consultant, Ob/Gyn Dept.
Rh Disease.
Rhesus isoimmunization
HEMOLYTIC DISEASE OF NEWBORN
New screening -Group B Streptococcus
Fetal Haemolytic Disease
Rheusus iso-Immunization
Blood Typing A, B, AB and O Blood Types.
Review of Blood type and Rh
New screening -Group B Streptococcus
Raina Raquel Flores, M.D. 3/7/14
Rheusus iso-Immunization L2
New screening -Group B Streptococcus
Presentation transcript:

Rh Isoimmunization

Immunologic disorder that occurs in pregnant Rh negative lady carrying Rh positive fetus

Pathophysiology The rhesus system which comprises number of antigens C, D, E, c, e. A person who lacks D antigen is called Rh negative. 15% of Caucasians, 5% African Americans and 2 % of Asians are Rh negative. Rh isoimmunisation is due to D antigen in more than 90% of cases. Occasionally hemolytic disease of the newborn is a result of maternal immunization to Irregular RBC antigens other than Rh group like anti- Kell and anti- Duffy

Pathophysiology Initial response is forming IgM antibodies for short period followed by production of IgG which crosses placenta IgG antibodies adhere to the antigen site on the surface of erythrocytes causing hemolysis. The excessive removal of circulatory RBCs leads to severe anemia and hypoxia. Erythropoiesis results in hepatosplenomegaly. Tissue hypoxia and hypoproteinemia results in cardiac and circulatory failure, with generalized odema and hydrops

Pathophysiology Maternal immune system becomes sensitized when there is fetal blood leak into the maternal circulation. Although leaks are common only 8% are sensitized within 6 months after first del of ABO compatible preg. 16% are sensitized after second full term pregnancy of Rh positive ABO compatible pregnancy. The risk of sensitization after ABO incompatible pregnancy is only 2% Risk after spontaneous miscarriage is 3.5% Risk after induce abortion is 5.5% Risk after ectopic pregnancy is about 1%

Natural History 50% of affected infants have no or mild anemia, requiring either phototherapy or no treatment. 25% have some degree of hepatosplenomegaly and moderate anemia and progressive jundice culminating in kernicterus, neonatal death or severe handicap. 25% are hydropic and usually die in utero or in the neonatal period ( half of these the hydrops develops before 34 weeks gestation ).

The aim of antenatal management To predict which pregnancy is at risk To predict whether or not the fetus is severely affected. To correct anemia and reverse hydrops by intrauterine transfusion. To deliver the baby at the appropriate time, weighing the risks of prematurity against these of intrauterine transfusion.

Recognition of pregnancy at risk First ante-natal visit check blood group, antibody screening. If indirect coombs test is positive, the father’s Rh should be tested. Serial maternal Anti D titers should be done every 2- 4 weeks. If titer is less than 1/16 the fetus is not at risk. If titer is more than 1/16 then severity of condition should be evaluated.

Prediction of the severity of fetal hemolysis History of previous affected pregnancies The levels of maternal hemolytic antibodies Amniocentesis Biophysical surveillance Fetal blood sampling

Amniocentesis There is an excellent correlation between the amount of bilirubin in amniotic fluid and fetal hematocrit. The optical density deviation at 450 nm measures the amniotic fluid unconjugated bilirubin.

Amniocentesis

Ultrasound detection of Rh Sensitization Serial U/S examination for fetal well being. Placental size and thickness and hepatic size. Fetal hydrops is easy to diagnose when finding one or more of the following: Ascites, pleural effusion, pericardial effusion, or skin edema. Doppler assessment of peak velocity of fetal middle cerebral artery proved to valuable in predicting fetal anemia

Biophysical surveillance Middle cerebral artery peak velocity

Biophysical surveillance Middle Cerebral Artery peak systolic velocity A = moderate-severe anaemia B = mild anaemia C = no anaemia 80 70 60 50 40 30 20 A 1.5 MOM B 1.29 MOM MCA peak velocity cm/sec C Median 20 25 30 35 Gestational Age (wks) from Mari et al, NEJM 2000; 342:9-14

Fetal Blood Sampling FBS Percutaneous Umbilical Blood Sampling BUBS Allows measurement of fetal Hb, Hct, pH, reticulocytes and nucleated RBCs. Risk fetal exanguination and fetal death 1%.

Fetal Blood Sampling

Confirmation of fetal blood Visualizing the needle tip within the cord vessel Turbulance when injecting a small amount of saline into the vessel. Fetal blood has a higher mean corpuscular volume ( MCV usually 100 fL An alkali elusion method can be used Acid elution Betke-Kleihauer test

Confirmation of fetal blood

Confirmation of fetal blood

Intrauterine Transfusion Radiologically guided intraperitoneal transfusion by Liley in 1963. Adoption of ultrasound guided IPT resulted in dramatic improvement in survival rates. Fetoscopic intravascular route was renewed by Rodeck in 1981. Percutaneous transfusion into the intrahepatic umbilical vein, Bang 1982. Cordocentesis, Daffos 1983. The use of cordocentesis for fetal top up transfusion by Berkowitz.

Intravascular transfusion IVT has superseded intraperitoneal transfusion in most centres. It has superior results, regarding survival rates, quality of survivors, prolongation of gestation and the higher rate of vaginal delivery. Access to the fetal circulation is extremely essential to avoid the lethal mistake of transfusing the Rh negative fetus or the nonanemic Rh positive fetus. Decisions regarding transfusion and delivery are made on the basis of fetal blood group, Hb estimation and other hematologic parameters . IVT results are better in the compromised hydropic fetus.

Intrauterine blood transfusion

Donor Blood Washed, filtered or irradiated with 2500 rad Gamma ray packed red blood cells with Hct 75% Group O negative heterologous blood Maternal blood

=(Gestation in weeks - 20) X 10 Transfusion volume (ml) =(Gestation in weeks - 20) X 10

Timing of transfusions Subsequent transfusions are timed on the basis of the fetal Hct achieved at the end of the previous transfusion and the rate of fall in fetal Hct. The latter has been reported to be on average equal to 1% of Hct/day

Complications of cordocentesis and intravascular transfuaion Hemorrhage. Hematomas.. Bradycardias. Fetomaternal hemorrhage. Infection. Abruptio placetae. Preterm labor.

Timing of Delivery Weighing the risk of fetal loss including that related to intrauterine transfusion against the risk of prematurity.

Prevention The widespread use of anti D prophylaxis in the late 1960s has led to a great reduction in isoimmunisation. Following delivery and caesarean section Routine anti D administration at 28 weeks. Following spontaneous and induced abortion. Vaginal bleeding and threatened miscarriage. Performing amniocentesis, CVS, Abdomenal trauma and external cephalic version.

Prevention The usual dose is 300 µg within 72 hours following delivery. This covers 30 ml of fetal blood leak into maternal circulation. If greater transplacental hemorrhage is suspected the dose should be tailored after Kleihauer- Betke test to determine the volume of hemorrhage.

Kleihauer- Betke test The adult hemoglobin is more readily acid eluted through the cell membrane than fetal hemoglobin. Maternal blood is fixed on a slide with ethanol 80%, treated with citrate phosphate buffer. After staining with hematoxylin and eosin the fetal cells will be stained while the adult cells appear like ghost cells. No. of fetal cells/ No. of adult cells is equal to fetal blood volume/ maternal blood volume.

Thank you